Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
Frontiers in Immunology
|
October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
Yun Ji, Qi Zhang, Lin Cheng, et al.
The Journal of General Virology
|
May 7, 2021
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
Joseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Cell Reports
|
May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Antiviral Research
|
September 13, 2017
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice
Derek R Stein, Joseph W Golden, Bryan D Griffin, et al.
Cell Reports
|
July 21, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
JCI Insight
|
August 26, 2020
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W Golden, Curtis R Cline, Xiankun Zeng, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Subunit recombinant vaccine protects against monkeypox
Jean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
Frontiers in Immunology
|
October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
Yun Ji, Qi Zhang, Lin Cheng, et al.
The Journal of General Virology
|
May 7, 2021
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
Joseph W Golden, Xiankun Zeng, Curtis R Cline, et al.
Cell Reports
|
May 5, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Antiviral Research
|
September 13, 2017
Human polyclonal antibodies produced in transchromosomal cattle prevent lethal Zika virus infection and testicular atrophy in mice
Derek R Stein, Joseph W Golden, Bryan D Griffin, et al.
Cell Reports
|
July 21, 2021
Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection
Taylor B Engdahl, Natalia A Kuzmina, Adam J Ronk, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
JCI Insight
|
August 26, 2020
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W Golden, Curtis R Cline, Xiankun Zeng, et al.
The Lancet. Infectious Diseases
|
August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
Angela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 5, 2006
Subunit recombinant vaccine protects against monkeypox
Jean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Page
of 21